NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Open Lending Corporation (NASDAQ: LPRO) between February 24, 2022 and March 31, 2025, both dates inclusive (the “Class Period”), of the important June 30, 2025 lead plaintiff deadline. SO WHAT: If you purchased Open Lending securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arra ...

集体诉讼案件 - 针对West Pharmaceutical Services公司（NYSE: WST）的集体诉讼案件，涉及2023年2月16日至2025年2月12日期间购买该公司普通股的投资者 [1] - 诉讼指控公司在上述期间内作出虚假或误导性陈述，包括未披露高价值产品（HVP）组合持续去库存化、SmartDose设备因运营效率低下导致利润率稀释等问题 [5] - 投资者需在2025年7月7日前申请成为首席原告 [1][3] 公司经营问题 - West Pharmaceutical Services声称对客户需求有清晰了解，并将阻力归因于临时性COVID相关产品去库存化，但实际上其高利润率HVP组合正经历显著且持续的去库存化 [5] - 公司SmartDose设备作为高利润率增长产品定位，但因运营效率低下对整体利润率产生稀释效应 [5] - 利润率压力导致公司可能退出与长期客户的连续血糖监测（CGM）合同，并面临成本高昂的重组活动 [5] 律所背景 - Rosen Law Firm专注于证券集体诉讼和股东衍生诉讼，曾创下针对中国公司的最大证券集体诉讼和解记录 [4] - 该律所2017年在证券集体诉讼和解数量方面被ISS Securities Class Action Services评为第一，2013年以来每年排名前四 [4] - 2019年该律所为投资者追回超过4.38亿美元 [4]

NEW YORK, May 26, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zenas BioPharma, Inc. (NASDAQ: ZBIO) pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with Zenas BioPharma’s September 2024 initial public offering (“IPO” or the “Offering”), of the important June 16, 2025 lead plaintiff deadline in the securities class action first filed by the firm ...

NEW YORK, May 26, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Digimarc Corporation (NASDAQ: DMRC) between May 3, 2024 and February 26, 2025, both dates inclusive (the “Class Period”), of the important July 8, 2025 lead plaintiff deadline. SO WHAT: If you purchased Digimarc securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHA ...

NEW YORK, May 26, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024 and October 16, 2024, both dates inclusive (the “Class Period”), of the important July 11, 2025 lead plaintiff deadline. SO WHAT: If you purchased Elevance common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement ...

案件背景 - Everus Construction Group Inc (NYSE ECG) 的普通股购买者在2024年10月31日至2025年2月11日期间（含首尾日期）可能有权获得赔偿 [1] - 包括在2024年10月21日持有MDU Resources Group Inc普通股并在2024年10月31日左右通过分拆获得Everus Construction普通股的投资者 [1] 诉讼细节 - 指控被告在诉讼期间做出虚假或误导性陈述或未披露以下信息 [5] - Everus Construction的项目积压转换周期因更大更复杂的项目而延长 [5] - 导致Everus Construction的收入确认延迟 [5] - 因此被告对Everus Construction业务、运营和前景的积极陈述在实质上具有误导性或缺乏合理依据 [5] 律所信息 - Rosen Law Firm专注于证券集体诉讼和股东衍生诉讼 [4] - 曾创下针对中国公司的最大证券集体诉讼和解记录 [4] - 2017年被ISS Securities Class Action Services评为证券集体诉讼和解数量第一 [4] - 自2013年以来每年排名前四 [4] - 2019年为投资者追回超过4.38亿美元 [4] - 2020年创始合伙人Laurence Rosen被law360评为原告律师界泰斗 [4] 参与方式 - 加入集体诉讼的截止日期为2025年6月3日 [1] - 可通过指定网站或联系方式参与 [3][6] - 在集体诉讼被认证前投资者不自动由律师代表 [7]

NEW YORK, May 23, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Digimarc Corporation (NASDAQ: DMRC) between May 3, 2024 and February 26, 2025, both dates inclusive (the “Class Period”), of the important July 8, 2025 lead plaintiff deadline. SO WHAT: If you purchased Digimarc securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHA ...

NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024 and October 16, 2024, both dates inclusive (the “Class Period”), of the important July 11, 2025 lead plaintiff deadline. SO WHAT: If you purchased Elevance common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement ...

NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Civitas Resources, Inc. (NYSE: CIVI) between February 27, 2024 and February 24, 2025, both dates inclusive (the “Class Period”), of the important July 1, 2025 lead plaintiff deadline. SO WHAT: If you purchased Civitas Resources securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO ...

NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Compass Diversified Holdings (NYSE: CODI) between May 1, 2024, and May 7, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 8, 2025 in the securities class action first filed by the Firm. SO WHAT: ...